Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Tetra Bio-Pharma News

    -   $ 0,00% +0,00 $
    In : -    € | 25.04.24 15:30:00 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2ASQ8
    ISIN: CA88166Y1007
    US-Symbol: TBPMQ
    Typ: Aktie

    Tetra Bio-Pharma News

    10.02.23 - PR Newswire
    Tetra Bio-Pharma Announces Listing to OTCPink Market
    Tetra Bio-​Pharma Announces Listing to OTCPink Market PR Newswire
    22.12.22 - PR Newswire
    REDUVO™ Marketing Approval on the Right Path
    REDUVO™ Marketing Approval on the Right Path PR Newswire
    06.12.22 - PR Newswire
    Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir
    Tetra Bio-​Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir PR Newswire
    29.11.22 - PR Newswire
    Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
    Tetra Bio-​Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003 PR Newswire
    18.11.22 - PR Newswire
    Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission
    Tetra Bio-​Pharma Provides Update on Its REDUVO™ New Drug Submission PR Newswire
    11.10.22 - PR Newswire
    Tetra and Prepaire Jointly Apply to BARDA for Funding
    Tetra and Prepaire Jointly Apply to BARDA for Funding PR Newswire
    08.09.22 - PR Newswire
    Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean
    Tetra Bio-​Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean PR Newswire
    06.09.22 - PR Newswire
    Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients
    Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients PR Newswire
    11.08.22 - PR Newswire
    Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean
    Tetra Bio-​Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean PR Newswire
    10.08.22 - PR Newswire
    Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections
    Tetra Bio-​Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections PR Newswire
    12.07.22 - PR Newswire
    Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
    Akanda to Supply Tetra Bio-​Pharma with Pharmaceutical-​Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug PR Newswire
    06.06.22 - PR Newswire
    Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update
    Tetra Bio-​Pharma Opens New Subsidiary in Australia and Provides Regulatory Update PR Newswire
    31.05.22 - PR Newswire
    Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting
    Tetra Bio-​Pharma Announces Voting Results of 2022 Annual General and Special Meeting PR Newswire
    30.05.22 - PR Newswire
    Tetra Bio-Pharma Appoints Chief Financial Officer
    Tetra Bio-​Pharma Appoints Chief Financial Officer PR Newswire
    18.05.22 - PR Newswire
    Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD
    Tetra Bio-​Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD PR Newswire
    17.05.22 - PR Newswire
    Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate
    Tetra Bio-​Pharma Announces Closing of First Tranche with Cannvalate PR Newswire
    10.05.22 - PR Newswire
    Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology
    Tetra Bio-​Pharma Announces Licensing Agreement with True North for Patented CBD Technology PR Newswire
    05.05.22 - PR Newswire
    Tetra Bio-Pharma and Cannvalate Enter Into Partnership
    Tetra Bio-​Pharma and Cannvalate Enter Into Partnership PR Newswire
    17.03.22 - PR Newswire
    Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA
    Tetra Bio-​Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA PR Newswire
    08.03.22 - PR Newswire
    Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD
    Tetra Bio-​Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD PR Newswire

    Newssuche

    Videos

    newspaper
    08:40 Uhr +6,45%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »